Furthermore, ROC curve analyses revealed a potential for the prediction of PCa risk reclassification for the uEV transcripts AMACR (AUC = 0.655, p = 0.025), HPN (AUC = 0.626, p = 0.068), MALAT1 (AUC = 0.614, p = 0.098), PCA3 (AUC = 0.617, p = 0.091), and PCAT29 (AUC = 0.627, p = 0.067) (Figure 3 and Table 3). The gene discussed is PCA3; the disease is posterior cortical atrophy.